About the Authors
Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado, United States of America
Nijmegen University Center for Infectious Diseases, Nijmegen, Netherlands
Laboratory of Experimental Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Division of Surgery, University of Colorado Health Sciences Center, Denver, Colorado, United States of America
Department of Immunohematology and Blood Transfusion, Leiden University, Leiden, Netherlands
Division of Pulmonary Sciences, University of Colorado Health Sciences Center, Denver, Colorado, United States of America
Department of Bioscience and Biotechnology, Konkuk University, Seoul, Korea
Department of Biomedical Science and Technology, Konkuk University, Seoul, Korea
The authors have declared that no competing interests exist.
MGN, DL, TO, SHK, and CAD designed the study. TA, ECL, LABJ, MW, DL, and XM collected data or did experiments for the study. TA helped generate recombinant IL-32. LABJ participated in IL-32 expression of PBMCs after exposure to LPS and MTB. MW participated in the immunocytochemistry for IL-32 staining in PBMCs treated with different stimuli and took the picture. DL provided the necessary mycobacterial stimulating components and help in using them in the experiments. DYY prepared anti-IL-32 antibodies. CAD developed the assays also. EDC participated in intellectual input and discussions with MGN. MGN, XM, TO, SHK, and CAD analyzed the data. MGN, EDC, TO, and CAD contributed to writing the paper.